ArticleAnnals of gastroenterology

Dual metformin and glucagon-like peptide-1 receptor agonist therapy reduces mortality and hepatic complications in cirrhotic patients with diabetes mellitus.

Daniel J Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.